Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysis

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.